2025-08-11 - Analysis Report
Okay, here's a report analyzing MercadoLibre Inc. (MELI) based on the data you provided.

## MercadoLibre Inc. (MELI) Stock Analysis

**Ticker:** MELI
**Company Name:** MercadoLibre Inc.
**Description:** MercadoLibre Inc. operates online marketplaces dedicated to e-commerce and related services in Latin America.

### 1. Performance vs. S&P 500 (VOO)

**Key Metrics:**

*   **MELI Cumulative Return:** 202.53%
*   **VOO (S&P 500) Cumulative Return:** 84.01%
*   **Absolute Spread (MELI - VOO):** 118.52% (202.53% - 84.01%)
*   **Spread Range (Max-Min):** Max: 344.1, Min: -6.8
*   **Current Spread:** 30.8
*   **Relative Spread:** 10.7

**Analysis:**

MELI has significantly outperformed the S&P 500 over the analyzed period. The absolute spread shows a considerable difference in cumulative returns, favoring MELI.  The relative spread indicates MELI is currently performing near the lower end of its historical outperformance range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD  | Alpha   | Beta | Cap(B) |
|------------|---------|------|---------|------|--------|
| 2015-2017  | 120.0%  | 54.1%| 117.0%  | 0.1  | 15.9   |
| 2016-2018  | 69.0%   | 65.8%| 73.0%   | 0.0  | 14.8   |
| 2017-2019  | 105.0%  | 65.8%| 82.0%   | 0.0  | 29.0   |
| 2018-2020  | 370.0%  | 66.3%| 343.0%  | 0.0  | 84.9   |
| 2019-2021  | 293.0%  | 66.3%| 243.0%  | 0.0  | 68.4   |
| 2020-2022  | -85.0%  | 70.6%| -92.0%  | 0.0  | 42.9   |
| 2021-2023  | -370.0% | 70.6%| -390.0% | 0.7  | 79.7   |
| 2022-2024  | -96.0%  | 70.6%| -122.0% | 0.7  | 86.2   |
| 2023-2025  | 27.0%   | 72.9%| -22.0%  | 0.4  | 119.3  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows highly variable performance across different periods, with some periods showing explosive growth (e.g., 2018-2020) and others significant declines (e.g., 2021-2023).
*   **MDD:** The Maximum Drawdown indicates substantial risk, with drawdowns consistently exceeding 50%, peaking at 72.9% for 2023-2025.
*   **Alpha:** Consistently high alpha during growth periods indicates significant outperformance relative to the benchmark, but becomes negative during downturns.
*   **Beta:** Consistently low beta from 2015-2021 indicates a low correlation to market movements. However, the recent rise in beta suggests the stock is becoming more sensitive to overall market trends, indicating high volatity.

### 2. Recent Stock Price Movement

*   **Current Price:** 2353.70
*   **Previous Close:** 2334.82
*   **Change:** 0.81%
*   **5-Day Moving Average:** 2361.92
*   **20-Day Moving Average:** 2376.59
*   **60-Day Moving Average:** 2463.59

**Analysis:**

The recent price increase of 0.81% suggests a slight upward trend. However, the current price is below both the 5-day, 20-day and 60-day moving averages, indicating potential short-term bearish momentum. The moving averages suggest a downtrend over the past 60 days.

### 3. Market Risk Indicators

*   **Market Risk Indicator (MRI):** 0.3323 (Low Risk)
*   **RSI:** 45.10
*   **PPO:** -0.0623
*   **Hybrid Signal:** cash_3%_Buy 80% of cash (18 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Spread Change:** -1.7 (Negative)
*   **Expected Return:** 289.3%

**Analysis:**

*   **MRI:** Indicates a low overall market risk environment.
*   **RSI:** A value of 45.10 suggests that the stock is neither overbought nor oversold, indicating a neutral momentum.
*   **PPO:** A negative PPO indicates that the shorter-term moving average is below the longer-term moving average, suggesting potential downward momentum.
*   **Hybrid Signal:** The hybrid signal suggests a cautious approach, recommending allocating 80% of available cash for purchasing 18 shares. This aligns with the low MRI and suggests a strategic buy on a pullback.
*   **Relative Spread Change:** A negative change suggests that MercadoLibre's performance relative to the S&P 500 has weakened recently, although it has outperformed the S&P 500 in the long-term.
*   **Expected Return:** The very high expected return (289.3%) suggests significant potential for long-term outperformance relative to the S&P 500, indicating that investing in this company from now for a long term (over 2 years) is expected to yield high profits.

### 4. Recent News & Significant Events

*   **[2025-08-10]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-08]:** Analysts discussing recent performance and outlook.
*   **[2025-08-07]:** Notable stock volatility.
*   **[2025-08-09]:** Market experts highlighting risks and opportunities.

**Analysis:**

Recent news suggests that MercadoLibre is experiencing volatility and is subject to analyst scrutiny due to ongoing market events and developments. Investors should monitor these events closely to understand potential impacts.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-08-05 | 10.31 | 4.80 B$    |
| 2025-05-08 | 9.74  | 4.19 B$    |
| 2024-11-07 | 7.83  | 3.90 B$    |
| 2024-08-02 | 10.48 | 3.77 B$    |
| 2025-08-05 | 10.48 | 3.77 B$    |

**Analysis:**

The EPS and revenue data present a mixed picture. While revenue generally shows an upward trend, EPS has fluctuated. The latest EPS is slightly lower than the previous quarter, but the revenue has increased. This can be caused by increased expenses.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $6.79B   | 45.57%        |
| 2025-03-31   | $5.93B   | 46.69%        |
| 2024-12-31   | $6.06B   | 45.37%        |
| 2024-09-30   | $5.31B   | 45.91%        |
| 2024-06-30   | $5.07B   | 46.62%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE    |
|--------------|----------|--------|
| 2025-06-30   | $5.71B   | 9.15%  |
| 2025-03-31   | $5.00B   | 9.87%  |
| 2024-12-31   | $4.35B   | 14.69% |
| 2024-09-30   | $4.00B   | 9.92%  |
| 2024-06-30   | $3.66B   | 14.52% |

**Analysis:**

*   **Revenue and Profitability:** Revenue shows consistent growth over the quarters, with profit margins remaining relatively stable around 45-47%.
*   **Capital and Profitability:** Equity has increased steadily, indicating growing financial strength. ROE (Return on Equity) has fluctuated, peaking in Q4 2024 and Q2 2024, and then has declined more recently.

### 7. Overall Assessment

MercadoLibre (MELI) presents a mixed picture for investors:

**Strengths:**

*   **Strong Historical Outperformance:** MELI has significantly outperformed the S&P 500 historically.
*   **Revenue Growth:** Consistent revenue growth and healthy profit margins demonstrate a strong business model.
*   **High Expected Returns:** Indicates significant potential for long-term gains.
*   **Low Market Risk Environment:** The MRI suggests a favorable market environment.
*   **Increasing Equity:** Growing equity base reflects increasing financial strength.

**Weaknesses/Risks:**

*   **Recent Underperformance:** Recent price action and relative spread change indicate short-term weakness.
*   **Earnings Volatility:** Fluctuations in EPS raise concerns about profitability consistency.
*   **High Volatility:** Significant drawdowns indicate considerable risk.
*   **Decreased ROE:** More recent decline in ROE indicates the growth momentum has slowed down.
*   **News-Driven Volatility:** Susceptible to market news and analyst sentiment, leading to stock volatility.

**Investment Recommendation:**

Based on the data provided, a cautious approach is warranted.

*   **Long-Term Investors:** Given the high expected return and historical outperformance, long-term investors might consider a strategic buy, especially if they believe in the company's long-term growth potential and can tolerate high volatility.
*   **Short-Term Investors:** Short-term traders should be cautious, as the recent price action and negative relative spread change suggest potential downward momentum.

**Disclaimer:** This analysis is based solely on the data provided and should not be considered financial advice. Investors should conduct their own due diligence and consider their individual risk tolerance before making any investment decisions.
